Enhancement effects of chicken interleukin-2 on immune responses of H<sub>5</sub> subtype avian influenza virus vaccines

In order to boost immune response of conventional vaccines, investigation was made on immunoadjuvants-eukaryotic expression plasmid (pCI-IL-2) and recombinant chicken IL-2 (rChIL-2) expressed in E. coli. The adjuvants were coadministrated with H<sub>5</sub> subtype inactivated avian infl...

Full description

Saved in:
Bibliographic Details
Main Authors: LIU Yan, YOU Zhen-qiang, XU Jian, ZHENG Jiang-tao, YU Lian
Format: Article
Language:English
Published: Zhejiang University Press 2005-11-01
Series:浙江大学学报. 农业与生命科学版
Subjects:
Online Access:https://www.academax.com/doi/10.3785/1008-9209.2005.06.0797
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In order to boost immune response of conventional vaccines, investigation was made on immunoadjuvants-eukaryotic expression plasmid (pCI-IL-2) and recombinant chicken IL-2 (rChIL-2) expressed in E. coli. The adjuvants were coadministrated with H<sub>5</sub> subtype inactivated avian influenza virus (AIV) vaccines. Non-immunized commercial chickens were injected initially at 25-day-old and boosted 2 weeks later. Proliferation responses of chicken periphery blood lymphocytes were measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenylt-etrazolium bromide (MTT) assay and the titers of specific antibodies to the H<sub>5</sub> vaccine by hemagglutinin inhibit (HI) test. As the results revealed, the cellular and humoral immune responses were significantly enhanced in the groups co-immunized with pCI-IL-2 or rChIL-2 compared to the group inoculated with H<sub>5</sub> vaccine only. No significant difference were found between the two co-immunized groups (P&lt;0.05). Peak values of MTT and HI in the rChIL-2 coinoculated group were attained 4 weeks after initial inoculation, which was earlier than the group coinoculated with pCI-IL-2. These results presented evidence that both pCI-IL-2 and rChIL-2 could be employed as effective immunoadjuvant to conventional vaccines against avian influenza.
ISSN:1008-9209
2097-5155